Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3659 studies found for:    Head and Neck Neoplasms [ CONDITION ] OR Mouth Neoplasms [ CONDITION ]
Show Display Options
Rank Status Study
1 Completed Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma
Conditions: Mouth Neoplasms;   Head and Neck Neoplasms;   Tongue Neoplasms;   Carcinoma, Squamous Cell
Intervention: Drug: Sirolimus
2 Recruiting Patient Evaluation for Head and Neck Surgery Branch Studies
Conditions: Head and Neck Neoplasms;   Pharyngeal Cancer;   Oral Cancer;   Carcinoma, Squamous Cell;   Laryngeal Cancer
3 Terminated Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer
Conditions: Head and Neck Neoplasms;   Laryngeal Neoplasms;   Mouth Neoplasms;   Pharyngeal Neoplasms
Interventions: Drug: cetuximab;   Drug: cisplatin (associated to radiotherapy)
4 Withdrawn ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer
Conditions: Lip and Oral Cavity Cancer;   Head and Neck Cancer;   Oropharyngeal Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: ONYX-015
5 Terminated Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer
Conditions: Carcinoma, Squamous Cell of Head and Neck;   Carcinoma, Squamous Cell;   Neoplasms, Squamous Cell;   Head and Neck Neoplasms;   Mouth Neoplasms;   Head and Neck Cancer
Intervention: Drug: Proxinium
6 Terminated Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer
Conditions: Squamous Cell Carcinoma of the Head and Neck;   Carcinoma, Squamous Cell;   Neoplasms, Squamous Cell;   Head and Neck Neoplasms;   Mouth Neoplasms;   Head and Neck Cancer
Intervention: Drug: Proxinium
7 Completed Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors
Conditions: Liver Metastasis;   Pelvic Cancer;   Head and Neck Cancer;   Sarcoma;   Rectal Cancer;   Breast Cancer;   Colorectal Cancer;   Mouth Cancer
Interventions: Drug: LS 11(Taporfin Sodium);   Device: Lumaflex Light Delivery Catheter
8 Completed Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer
Conditions: Carcinoma, Squamous;   Head and Neck Cancer;   Oral Cancer;   Laryngeal Cancer;   Pharyngeal Cancer
Interventions: Drug: Bortezomib (Velcade, PS-341);   Drug: Cetuximab;   Drug: Cisplatin;   Procedure: Radiation Therapy
9 Completed Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma
Conditions: Head and Neck Cancer;   Oral Cavity Cancer;   Oropharyngeal Cancer
Intervention: Drug: Valproic Acid
10 Active, not recruiting F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients
Conditions: Mouth Neoplasms;   Oropharyngeal Neoplasms;   Laryngeal Neoplasms;   Head and Neck Neoplasms
Intervention: Drug: F-18 Fluorothymidine
11 Withdrawn Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema
Conditions: Lymphedema;   Oropharyngeal Cancer;   Head and Neck Cancer;   Oral Cancer
Interventions: Other: Follow -Up Visits;   Other: Full CDT;   Other: Modified CDT Program
12 Recruiting Oral Cancer Adjuvant Therapy (OCAT) Trial
Condition: Mouth Neoplasms
Intervention: Procedure: Post-operative chemoradiotherapy / accelerated radiotherapy
13 Completed A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations
Conditions: Mouth Cancer;   Lip Cancer;   Throat Cancer;   Lip Neoplasms;   Head and Neck Cancers
14 Suspended Pembrolizumab in Combination With CRT for LA-SCCHN
Conditions: Head and Neck Cancer;   Squamous Cell Carcinoma;   Oral Cavity Cancer;   Oropharynx Cancer;   Hypopharynx Cancer;   Larynx Cancer;   Laryngeal Cancer
Interventions: Drug: pembrolizumab (MK-3475);   Drug: Cisplatin;   Radiation: Radiation
15 Completed Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery
Conditions: Oral Cancer;   Head and Neck Cancer;   Free Flap;   Hypotension
Interventions: Drug: Epinephrine;   Drug: Norepinephrine;   Drug: Dobutamine;   Drug: Dopexamine
16 Completed Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer
Conditions: Head and Neck Cancer;   Parotid Gland Cancer;   Thyroid Gland Cancer;   Melanoma;   Stage IV Head and Neck Cancer
Interventions: Drug: Cisplatin;   Drug: Docetaxel;   Drug: Bevacizumab;   Drug: Erlotinib;   Radiation: Radiotherapy
17 Recruiting Polarized Reflectance Spectroscopy for Oral Lesions
Condition: Oral Cancer
Intervention: Device: Polarized Reflectance Spectroscopy System
18 Recruiting Validation of DNA Methylation Biomarkers for Oral Cancer Detection
Conditions: Oral Cancer;   Recurrence
19 Recruiting Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.
Conditions: Oropharyngeal Cancer;   Oral Cancer;   Lymph Node Metastasis
Intervention: Radiation: Radiation therapy
20 Active, not recruiting IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC
Conditions: Oral Cancer;   Oropharynx Cancer;   Hypopharynx Cancer
Interventions: Procedure: IMRT 75 Gy;   Procedure: Conventional radiotherapy 70 Gy;   Drug: concomitant cisplatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years